Pandion Therapeutics snags $58 mln Series A
Cambridge, Massachusetts-based Pandion Therapeutics, a biotech company, has closed $58 million in Series A financing. Polaris Partners, Versant Ventures and Roche Venture Fund led the round with participation from SR One and BioInnovation Capital.
18 January 2018•1 min read
